Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy
Thyroid Cancer, Thyroid Carcinoma, Papillary, Thyroid Metastases
About this trial
This is an interventional diagnostic trial for Thyroid Cancer focused on measuring Near-infrared (NIR) fluorescence, Total thyroidectomy, Parathyroid glands, Indocyanine green (ICG), Central lymph node dissection
Eligibility Criteria
Inclusion Criteria:
- Thyroid carcinoma patients (biopsy/cytology-proven) suitable for total thyroidectomy procedure
- Patients at or over 17 years
Exclusion Criteria:
- Previous thyroid surgery
- Patients below 17 years
Sites / Locations
- Umraniye Education and Research Hospital, Department of General SurgeryRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Thyroid carcinoma patients (biopsy-proven)-Total thyroidectomy
Thyroid carcinoma patients (biopsy-proven)-Sentinel lymph node
Control group-Total thyroidectomy (TT) with central lymph node dissection (CLND) procedure for patients with papillary thyroid carcinoma (PTC) Standard TT+CLND procedure only
Experimental group- Sentinel lymph node dissection (SLND) after intratumoral indocyanine green (ICG) injection and visualization of all 4 parathyroid glands with infra-red (NIR) fluorescence after intravenous (iv) ICG injection, during total thyroidectomy and central lymph node dissection (CLND). TT+CLND with NIR fluorescence ICG